A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Clinical trial NCT01304524 · COMPLETED
Trial details
- NCT number
- NCT01304524
- Sponsor
- Inovio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2014-05-01
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.